CD40LG and colorectal carcinoma: Within the realm of inflammatory markers, the platelet-to-lymphocyte ratio has emerged as a promising tool for evaluating the prognosis of CRC [33], indicating an association among activated platelets, elevated sCD40L, and poor prognosis of CRC patients.